First Childhood Exposure Determines How Sick You Get From Flu As Adult

MedicalResearch.com Interview with:
Katelyn M. Gostic and
Monique Ambrose

Department of Ecology and Evolutionary Biology
University of California
Los Angeles

MedicalResearch.com: What is the background for this study? What are the main findings?

Monique Ambrose: Influenza pandemics pose a serious, recurrent threat to human public health. One of the most probable sources of future pandemic influenza viruses is the pool of influenza A virus (IAV) subtypes that currently circulate in non-human animals. It has traditionally been thought that the human population is immunologically naïve and unprotected against these unfamiliar subtypes. However, our work suggests that an individual ‘imprints’ to the influenza A virus (IAV) encountered in early childhood in such a way that they retain protection against severe disease if they later encounter a novel IAV subtype that belongs to the same genetic group as their first exposure.

Our research looked at human cases of H5N1 and H7N9, two avian IAV subtypes of global concern, to investigate what factors most strongly predicted risk of severe disease. The most striking explanatory factor was childhood IAV imprinting: our results suggest that individuals who had childhood imprinting on an IAV in the same genetic group as the avian IAV they encountered later in life experienced 75% protection against severe disease and 80% protection against death.

MedicalResearch.com: What should readers take away from your report?

Monique Ambrose: We’ve found striking real-world evidence that the subtype of influenza you’re exposed to in early childhood affects how sick you get when you’re exposed to a new strain of influenza that you’ve never encountered before. This has very relevant implications for managing our resources during the next influenza pandemic. We can predict which groups of people are at greater risk of experiencing a severe or fatal infection and which groups are most likely to have some protection from protective childhood imprinting. This can help us determine how to distribute vaccines or otherwise target our control actions.

MedicalResearch.com: What recommendations do you have for future research as a result of this study?

Katelyn M. Gostic: There are a number of needed follow-up studies.

First and foremost, while our study clearly demonstrates the population-level consequences of childhood HA imprinting, the specific immune mechanism responsible for these patterns remains unknown. We proposed a number of promising candidate mechanisms in the published manuscript, but we are still working with laboratory scientists and immunologists to test these hypotheses.

On a similar note, we are not yet sure if HA imprinting protection prevents infection entirely, or merely reduces the severity of infection in protected individuals.

MedicalResearch.com: Is there anything else you would like to add?

Katelyn M. Gostic: One interesting aspect of this research is its potential relevance to the 1918 influenza pandemic, which infamously killed huge numbers of otherwise healthy 20-30 year-olds. Why the 1918 pandemic was so deadly, and why it disproportionately affected young adults is one of the great mysteries in epidemiology, and has still not been fully resolved. The HA imprinting patterns examined in our study actually grew out of an idea put forward by senior author Dr. Mike Worobey, which says that mismatched (group 2) childhood imprinting among the 20-30 year-olds of 1918 may explain why this group suffered so much mortality from the 1918 (group 1) pandemic strain.

MedicalResearch.com: Thank you for your contribution to the MedicalResearch.com community.

Citation:

James O. Lloyd-Smith et al. Potent protection against H5N1 and H7N9 influenza via childhood hemagglutinin imprinting. Science, November 2016 DOI: 10.1126/science.aag1322

Note: Content is Not intended as medical advice. Please consult your health care provider regarding your specific medical condition and questions.

More Medical Research Interviews on MedicalResearch.com

Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.